Solasia Pharma KK

TSE:4597 (Japan)  
円 36.00 (-2.7%) Dec 25
At Loss
P/B:
3.66
Market Cap:
円 8.06B ($ 49.83M)
Enterprise V:
円 7.16B ($ 44.12M)
Volume:
15.01M
Avg Vol (2M):
15.09M
Warning! GuruFocus detected 2 Severe warning signs with 4597. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
15.01M
Market Cap 円:
8.06B
Market Cap $:
49.83M
At Loss
Avg Vol (2M):
15.09M
Enterprise Value 円:
7.16B
Enterprise Value $:
44.12M
PB Ratio:
3.66
Alerts Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Solasia Pharma KK

ISIN : JP3436500007
https://www.solasia.co.jp
2-1-1 Shiba Park, 4th Floor, Sumitomo Real Estate Shiba Park Tower, Minato-ku, Tokyo, JPN, 105-0011
Compare
Compare
TSE:4582TSE:4524TSE:4512TSE:4883TSE:4539TSE:4586TSE:4892TSE:4574TSE:4538TSE:9273ZTSXTER:MRKNSE:SUNPHARMALSE:HLNTSE:4502XSWX:GALDXTAE:TEVANSE:DIVISLABXSWX:SDZVTRS
Traded in other countries / regions
4597.Japan9SO.Germany
IPO Date
2017-03-24
Description
Solasia Pharma KK develops and distributes pharmaceuticals and medical devices relating to malignant tumors.

Financial Strength

7/10
Name Current Vs Industry Vs History
Cash-To-Debt 21.41
Equity-to-Asset 0.86
Debt-to-Equity 0.02
Debt-to-EBITDA -0.05
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 11.96
Distress
Grey
Safe
Beneish M-Score -5.11
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

8/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -1.7
3-Year EBITDA Growth Rate 50.3
3-Year EPS without NRI Growth Rate 42.7
3-Year FCF Growth Rate 56.1
3-Year Book Growth Rate -28.7
Future 3-5Y EPS without NRI Growth Rate 44.1
Future 3-5Y Total Revenue Growth Rate 61.79

Momentum Rank

3/10
Name Current Vs Industry Vs History
5-Day RSI 13.5
9-Day RSI 23.13
14-Day RSI 30.37
6-1 Month Momentum % 82.76

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.87
Quick Ratio 3.42
Cash Ratio 3.11
Days Inventory 424.73
Days Sales Outstanding 415.5
Days Payable 785.08

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.4
Shareholder Yield % -13.98

Profitability Rank

1/10
Name Current Vs Industry Vs History
Gross Margin % 30.82
Operating Margin % -810.06
Net Margin % -808.18
FCF Margin % -316.35
ROE % -65.51
ROA % -52.7
ROIC % -81.27
ROC (Joel Greenblatt) % -688.17
ROCE % -63.78

GF Value Rank

1/10
Name Current Vs Industry Vs History
PS Ratio 40
PB Ratio 3.66
Price-to-Tangible-Book 7.5
EV-to-EBIT -5.38
EV-to-EBITDA -7.58
EV-to-Revenue 43.66
EV-to-FCF -14.23
Price-to-Net-Current-Asset-Value 8.57
Price-to-Net-Cash 11.8
Earnings Yield (Greenblatt) % -18.59
FCF Yield % -6.41

Financials

TSE:4597's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Solasia Pharma KK Executives

Details

GF Value: 円9.45

TSE:4597

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円) 159
EPS (TTM) (円) -7.37
Beta 0.36
Volatility % 135.53
14-Day RSI 30.37
14-Day ATR (円) 2.970639
20-Day SMA (円) 44.35
12-1 Month Momentum % 0
52-Week Range (円) 23 - 70
Shares Outstanding (Mil) 217.76

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Solasia Pharma KK Filings

Filing Date Document Date Form
No Filing Data

Solasia Pharma KK Stock Events

Financials Calendars
Event Date Price(円)
No Event Data

Solasia Pharma KK Frequently Asked Questions

What is Solasia Pharma KK(TSE:4597)'s stock price today?
The current price of TSE:4597 is 円36.00. The 52 week high of TSE:4597 is 円70.00 and 52 week low is 円23.00.
When is next earnings date of Solasia Pharma KK(TSE:4597)?
The next earnings date of Solasia Pharma KK(TSE:4597) is .
Does Solasia Pharma KK(TSE:4597) pay dividends? If so, how much?
Solasia Pharma KK(TSE:4597) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.